14 March 2026
Disclaimer: This is a simplified summary of a public company filing. See full disclaimer here.
Coherus Oncology, Inc.
CIK: 1512762•2 Annual Reports•Latest: 2026-03-09
10-K / March 9, 2026
Revenue:$42,172,000
Income:$168,024,000
10-K / March 17, 2025
Revenue:$206,000,000
Income:$28,507,000
10-K / March 9, 2026
Unknown Company
Document
- Form 10-K, Part I
Part I sections (with pages)
- Item 1. Business (5)
- Item 1A. Risk Factors (22)
- Item 1B. Unresolved Staff Comments (60)
- Item 1C. Cybersecurity (60)
- Item 2. Properties (61)
- Item 3. Legal Proceedings (61)
- Item 4. Mine Safety Disclosures (61)
Inference
- The filing follows the standard Part I structure for a Form 10-K.
- The presence of a Mine Safety Disclosures section is consistent with filings from companies involved in mining or mineral-related operations.
Next steps
Please provide the text for the following sections (or the relevant figures) to produce a detailed, numbers-based summary:
- Item 1. Business (description of products/services, markets, key customers)
- Item 8. Financial Statements and Supplementary Data (revenue, net income, and other financial metrics)
Once you share those sections I will summarize:
- Company overview (core products/services and markets)
- Number of customers and employees (if stated)
- Revenue and net income (and other key financial figures provided)
- Other operational details (geography, major customers, dependencies)
